Drugs Made In America Acquisition Corp. (DMAAU) Assets Average (2025)
Drugs Made In America Acquisition's (DMAAU) quarterly Assets Average came in at $238.8 million in Q4 2025, up 1.0% on a QoQ basis from $236.4 million in Q3 2025.
Drugs Made In America Acquisition Corp. (DMAAU) Assets Average (2025) Analysis & Trends
Drugs Made In America Acquisition (DMAAU) has 1 years of Assets Average data on file, last reported at $238.8 million in Q4 2025.
- Quarterly Assets Average changed N/A year-over-year to $238.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $238.8 million (changed N/A YoY) and the FY2025 annual result came in at $120.2 million, changed N/A from the prior year.
- Assets Average grew to $238.8 million in Q4 2025, from $236.4 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $238.8 million in Q4 2025 to a low of $116.7 million in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 238.78 Mn |
| Sep 30, 2025 | 236.42 Mn |
| Jun 30, 2025 | 234.01 Mn |
| Mar 31, 2025 | 116.68 Mn |